{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T09:41:14Z","timestamp":1759830074664,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.drugalcdep.2019.05.016","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T11:37:25Z","timestamp":1567165045000},"page":"107484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antibody production and pharmacokinetics of METH in rats following vaccination with the METH vaccine, IXT-v100, adjuvanted with GLA-SE"],"prefix":"10.1016","volume":"204","author":[{"given":"Misty W.","family":"Stevens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"R\u00fcedi-Bettschen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melinda G.","family":"Gunnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Tawney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. Michael","family":"West","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Michael","family":"Owens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0005","first-page":"253","article-title":"Preclinical efficacy of an anti\u2010methamphetamine vaccine using E6020 adjuvant","volume":"27","author":"Arora","year":"2019","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0010","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pr.117.013904","article-title":"Conjugate Vaccine Immunotherapy for Substance Use Disorder","volume":"69","author":"Bremer","year":"2017","journal-title":"- PubMed - NCBI. Pharmacol. Rev."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0015","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0014-2999(03)01313-X","article-title":"Pharmacodynamic mechanisms of monoclonal antibody-based antagonism of (+)-methamphetamine in rats","volume":"461","author":"Byrnes-Blake","year":"2003","journal-title":"Eur. J. Pharmacol."},{"year":"2016","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2015 National Survey on Drug Use and Health [WWW Document]. samhsa.gOv","author":"Center for Behavioral Health Statistics and Quality","key":"10.1016\/j.drugalcdep.2019.05.016_bib0020"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0025","first-page":"e13677","volume":"Vol. 5","author":"Coler","year":"2010"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0030","doi-asserted-by":"crossref","first-page":"e16333","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"Coler","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0035","series-title":"The TLR-4 Agonist Adjuvant, GLA-SE, Improves Magnitude and Quality of Immune Responses Elicited by the ID93 Tuberculosis Vaccine: First-in-human Trial. Npj Vaccines 2018 3:1 3","first-page":"34","author":"Coler","year":"2018"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0040","doi-asserted-by":"crossref","first-page":"3878","DOI":"10.1021\/acs.jmedchem.6b00084","article-title":"Methamphetamine vaccines: improvement through hapten design","volume":"59","author":"Collins","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.drugalcdep.2014.08.003","article-title":"Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature","volume":"143","author":"Courtney","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0050","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1016\/j.vaccine.2009.02.105","article-title":"Immune responses to methamphetamine by active immunization with peptide-based, molecular adjuvant-containing vaccines","volume":"27","author":"Duryee","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0055","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1600-065X.2010.00978.x","article-title":"Use of defined TLR ligands as adjuvants within human vaccines","volume":"239","author":"Duthie","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0060","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1021\/acschemneuro.6b00389","article-title":"Influencing antibody-mediated attenuation of methamphetamine CNS distribution through vaccine linker design","volume":"8","author":"Gooyit","year":"2017","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0065","doi-asserted-by":"crossref","DOI":"10.4155\/fmc.11.190","article-title":"Pharmacokinetic strategies for treatment of drug overdose and addiction","author":"Gorelick","year":"2012","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0070","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1021\/acs.jmedchem.5b00220","article-title":"Combining active immunization with monoclonal antibody therapy to facilitate early initiation of a long-acting anti-methamphetamine antibody response","volume":"58","author":"Hambuchen","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0075","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1124\/dmd.31.11.1320","article-title":"Use of anti-(+)-methamphetamine monoclonal antibody to significantly alter (+)-methamphetamine and (+)-amphetamine disposition in rats","volume":"31","author":"Laurenzana","year":"2003","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0080","doi-asserted-by":"crossref","first-page":"2638","DOI":"10.4161\/hv.29707","article-title":"Pharmacological effects of two anti-methamphetamine monoclonal antibodies. Supporting data for lead candidate selection for clinical development","volume":"10","author":"Laurenzana","year":"2014","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0085","first-page":"e63785","volume":"Vol. 8","author":"Matthews","year":"2013"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114366","article-title":"Novel anti-nicotine vaccine using a trimeric coiled-coil hapten carrier","volume":"9","author":"Miller","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0095","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.drugalcdep.2015.06.014","article-title":"Effects of active anti-methamphetamine vaccination on intravenous self-administration in rats","volume":"153","author":"Miller","year":"2015","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0100","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.biopsych.2012.09.010","article-title":"A methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in rats","volume":"73","author":"Miller","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0105","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugalcdep.2017.03.005","article-title":"Effective active vaccination against methamphetamine in female rats","volume":"175","author":"Nguyen","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0110","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1021\/bc500456z","article-title":"Simple radiometric method for accurately quantitating epitope densities of hapten-protein conjugates with sulfhydryl linkages","volume":"25","author":"Peterson","year":"2014","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0115","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1016\/j.vaccine.2013.07.038","article-title":"Vaccination protects rats from methamphetamine-induced impairment of behavioral responding for food","volume":"31","author":"R\u00fcedi-Bettschen","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0120","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.drugalcdep.2012.09.007","article-title":"A vaccine against methamphetamine attenuates its behavioral effects in mice","volume":"129","author":"Shen","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0125","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2011.281","article-title":"Vaccines against drug abuse","volume":"91","author":"Shen","year":"2012","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0130","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.intimp.2016.03.028","article-title":"Optimization of a methamphetamine conjugate vaccine for antibody production in mice","volume":"35","author":"Stevens","year":"2016","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0135","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.4161\/19420862.2014.976431","article-title":"First human study of a chimeric anti-methamphetamine monoclonal antibody in healthy volunteers","volume":"6","author":"Stevens","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0140","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2013.08.064","article-title":"Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5\/Indonesia\/05\/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant","volume":"31","author":"Treanor","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0145","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3389\/fimmu.2014.00316","article-title":"A comparative review of toll-like receptor 4 expression and functionality in different animal species","volume":"5","author":"Vaure","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.drugalcdep.2019.05.016_bib0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.biomaterials.2017.01.038","article-title":"Engineering of a hybrid nanoparticle-based nicotine nanovaccine as a next-generation immunotherapeutic strategy against nicotine addiction: a focus on hapten density","volume":"123","author":"Zhao","year":"2017","journal-title":"Biomaterials"}],"container-title":["Drug and Alcohol Dependence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619302431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0376871619302431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T08:59:48Z","timestamp":1759827588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0376871619302431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":30,"alternative-id":["S0376871619302431"],"URL":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.05.016","relation":{},"ISSN":["0376-8716"],"issn-type":[{"type":"print","value":"0376-8716"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibody production and pharmacokinetics of METH in rats following vaccination with the METH vaccine, IXT-v100, adjuvanted with GLA-SE","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.05.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107484"}}